Resistance exercise and non-alcoholic fatty liver disease

ISRCTN ISRCTN26705810
DOI https://doi.org/10.1186/ISRCTN26705810
Secondary identifying numbers 6955; G0802536
Submission date
23/04/2010
Registration date
23/04/2010
Last edited
29/07/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Dr Michael Trenell
Scientific

Westgate Road
Newcastle Upon Tyne
NE4 6BE
United Kingdom

Study information

Study designNon-randomised interventional prevention and treatment trial
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)GP practice
Study typePrevention
Participant information sheet Not available in web format, please contact kate.hallsworth@ncl.ac.uk to request a patient information sheet
Scientific titleThe effect of resistance exercise on metabolism and liver lipid in people with non-alcoholic fatty liver disease
Study hypothesisThe purpose of the study is to characterise the effects of resistance exercise upon factors which influence the development and progression of non-alcoholic fatty liver disease (NAFLD). The primary aim is to observe whether performing resistance exercise reduces liver lipid content in people with NAFLD. The secondary aims are to understand the influence of resistance exercise upon factors which influence the development of NAFLD: insulin sensitivity, lipid oxidation, regional adiposity and cytokine production.
Ethics approval(s)County Durham and Tees Valley 2 REC approved on the 28th September 2009 (ref: 09/H0908/48)
ConditionTopic: Metabolic and Endocrine, Oral and Gastrointestinal; Subtopic: Metabolic and Endocrine (all Subtopics); Disease: Metabolic & Endocrine (not diabetes), Hepatology
InterventionParticipants will be assigned to the exercise or control group. The exercise group will undergo 8 weeks of resistance training 3 times per week. The intensity of the programme will be tailored to each individual and be increased progressively over the 8 weeks. The control group will continue with standard clinical care. Follow up length: 4 months.
Intervention typeOther
Primary outcome measureA quantitative measure of liver fat will be made using H magnetic resonance spectroscopy. Primary and secondary outcome measures will be made at baseline and after the 8 week exercise intervention/8 week control period.
Secondary outcome measures1. Insulin sensitivity
2. Lipid oxidation
3. Cytokine production
4. Regional adiposity
5. Body composition

Primary and secondary outcome measures will be made at baseline and after the 8 week exercise intervention/8 week control period.
Overall study start date01/08/2009
Overall study end date01/06/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 28; UK Sample Size: 28
Participant inclusion criteria1. Diagnosed NAFLD or raised liver enzymes
2. Type 2 diabetes (diet or metformin controlled)
3. Body mass index (BMI) between 25 - 35 kg/m^2
4. Aged 18 - 70 years
5. Subjects should not already take part in regular exercise
Participant exclusion criteria1. Subjects with kidney disease or in vivo ferrous metal
2. Subjects that have other pre-existing medical conditions which could prevent them from exercising 3 x per week
3. Subjects with type 2 diabetes on insulin or insulin sensitising treatments
4. Subjects with advanced liver disease
Recruitment start date01/08/2009
Recruitment end date01/06/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Westgate Road
Newcastle Upon Tyne
NE4 6BE
United Kingdom

Sponsor information

Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

Midwifery Research Dept
Leazes Wing
Queen Victoria Road
Newcastle upon Tyne
NE1 4LP
England
United Kingdom

Website http://www.newcastle-hospitals.org.uk/
ROR logo "ROR" https://ror.org/05p40t847

Funders

Funder type

Research council

Diabetes UK (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
DIABETES UK LIMITED, British Diabetic Association
Location
United Kingdom
Medical Research Council (MRC) (UK) (ref: G0802536)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2011 Yes No